Methylphenidate Patch

Methylphenidate Patch
Product Description

Amarin patch is 33% smaller ant it also has one third less of the drug content. As the patch delivers the same amount of drug, this makes it 149% more efficient in comparison to the originator.

 Additionally, there has been multiple customers complains on Dyatrana due to backing removal is tough and often leads to adhesive loss and patch discard. Amarin patch does not present any removal or adhesive difficulties, as it is composed by a different adhesive.

 

Additionally, the shelf life of our product is 24 months (stability data for zone II and zone IVb), which represent 50% more than Daytrana (16 months).

Read more Show less

Amarin Technologies SA

  • Country/Region:
    Argentina
  • On CPHI since:
    2019
  • Certificates:
    2
  • Employees:
    25 - 49
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    The formulation developed by Amarin is a Drug-In adhesive patch, designed to be the first generic non-copycat formulation of Daytrana® (Noven Pharmaceuticals, USA), which is the Reference Listed Drug.

    The indication is: treatment of the Attention Deficit Hyperactivity Disorder (ADHD) in children of 6 to 12 years old and teens ranging from 13 to 17 years old.

    It is presented in 4 dosage strengths: 10 mg/9h, 15 mg/9h, 20 mg/9h and 30 mg/9h

More specifications Fewer specifications

Amarin Technologies SA

  • Country/Region:
    Argentina
  • On CPHI since:
    2019
  • Certificates:
    2
  • Employees:
    25 - 49
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
View company profile

More Products from Amarin Technologies SA (2)

  • Buprenorphine Patch

    Product Buprenorphine Patch

    Amarin has developed a patch intended to be AB rated to Butrans®, but with the comparative advantages of having half of the drug content and also a reduced size (having less residual drug after 7 days of use). As the patch delivers the same amount of drug, this makes it more efficient.

    O...
  • Fentanyl Patch

    Product Fentanyl Patch

    Fentanyl is a synthetic analgesic related to phenylpiperidines, which interacts predominately with the opioid μ-receptor. Fentanyl primary actions are analgesia and sedation. Minimum effective analgesic serum concentrations of fentanyl in opioid naive patients range from 0.2 to 1.2 ng/mL, and side effects ...

Amarin Technologies SA resources (1)